The US Army Medical Research Acquisition Activity proposes to award to BioReliance, Rockville, MD on a sole source basis, for services to conduct stability test of two lots of Heptavalent Equine Botulism Antitoxins. This is the only known laboratory in the U.S. that has developed validated stability test methods for this product. Testing at various laboratories can introduce variability in test results and render results open to interpretations. In order to minimize inter-laboratory variability, it is prudent to test the antitoxin at one laboratory with validated methods. This procurement shall be under other than full and open competition procedures in accordance with FAR 6.302-1. Only one responsible source and no other supplies or services will satisfy agency requirements. This notice is not a request for a competitive quote. Any response to this notice must be submitted in writing to the Government and show clear and convincing evidence that another source is capable of meeting the Governments requirements and that competition of the requirement would be advantageous to the Government. If no written responses are received at least fifteen (15) days after the publication of this response, the purchase will be awarded without further notice. The Point of Contact (POC) for this action is:
[email protected].